Martin Hensel

5 takeaways from a recent earnings call with the leading CGM maker.

The company plans to submit the pump system for FDA approval in 2017.

This might open up pump therapy for more young children.

Stephen A. Smith confuses Type 1 diabetes and Type 2 diabetes while trashing Cutler on ESPN.

A profile of an endurance athlete with Team Novo Nordisk.

It’s part of an effort to win FDA approval for two-drug treatments for Type 1 diabetes.

It expands who can provide diabetes care during the school day.

If adopted, the proposed regulations would sanction Dexcom G5 users to dose based on CGM readings.

Candidates love to sling mud at each other, but no one brought up May’s diabetes. Why?

Newsflash - diabetes is expensive. (Sigh.)

Readers speak about our story on the interrupted softball career of Lundyn Cox.

A certified diabetes educator provides a step-by-step process.

She joins another team and gets poetic justice during a tournament at season’s end.

Dubai airport security wanted to put the pump through an x-ray machine, and the family refused.

He is the second patient to be successfully treated by the experimental treatment, which was invented by the Diabetes Research…

Diabetes advocacy slams up against a complicated lawmaking process in the Pennsylvania legislature.

Insulin Nation readers shared their thoughts on whether or not to whip out the needle or pen where others can…

We share some of the best comments in reaction to the controversy.

That accelerated process may soon yield Medtronic’s application to bring an artificial pancreas to market.

Didn’t have time to read about Mike’s Pig Pen? We’ve got some silly pictures to help explain it.